Evidence map›Paper›PMID 36251729›Full record

ArticlePLoS neglected tropical diseases2022

"Candidatus Campylobacter infans" detection is not associated with diarrhea in children under the age of 2 in Peru.

Paul F Garcia Bardales, Francesca Schiaffino, Steven Huynh, Maribel Paredes Olortegui, Pablo Peñataro Yori, Tackeshy Pinedo Vasquez, Katia Manzanares Villanueva, Greisi E Curico Huansi, Wagner V Shapiama Lopez, Kerry K Cooper and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Paul F Garcia BardalesAsociacion Benefica Prisma, Iquitos, Peru.
Francesca SchiaffinoDivision of Infectious Diseases, University of Virginia, Charlottesville, Virginia, United States of America.
Steven HuynhAgricultural Research Service, U.S. Department of Agriculture, Produce Safety and Microbiology Research Unit, Albany, California, United States of America.
Maribel Paredes OlorteguiAsociacion Benefica Prisma, Iquitos, Peru.
Pablo Peñataro YoriAsociacion Benefica Prisma, Iquitos, Peru.
Tackeshy Pinedo VasquezAsociacion Benefica Prisma, Iquitos, Peru.
Katia Manzanares VillanuevaAsociacion Benefica Prisma, Iquitos, Peru.
Greisi E Curico HuansiAsociacion Benefica Prisma, Iquitos, Peru.
Wagner V Shapiama LopezAsociacion Benefica Prisma, Iquitos, Peru.
Kerry K CooperSchool of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, Arizona, United States of America.
Craig T ParkerAgricultural Research Service, U.S. Department of Agriculture, Produce Safety and Microbiology Research Unit, Albany, California, United States of America.
Margaret N KosekAsociacion Benefica Prisma, Iquitos, Peru.ORCID 0000-0001-6340-4852
Prisma · PEAgricultural Research Service · USUniversidad Peruana Cayetano Heredia · PEUniversity of Arizona · US

Funding

Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income CountriesR01AI158576 · NIAID · UNIVERSITY OF VIRGINIA · PI KOSEK, MARGARET N · 2021 to 2025
$3.3M
Enabling Infectious Disease Research Capacity in the Peruvian AmazonD43TW010913 · FIC · UNIVERSITY OF VIRGINIA · PI Margaret N Kosek, MARIBEL PAREDES OLORTEGUI · 2018 to 2026
$2.8M
Genomic features of host adaptation of Campylobacter in low-income settingsR21AI163801 · NIAID · UNIVERSITY OF VIRGINIA · PI KOSEK, MARGARET N, PARKER, CRAIG THOMAS · 2022 to 2023
$378k
FIC NIH HHS D43 TW010913NIAID NIH HHS R01 AI158576NIAID NIH HHS R21 AI163801
6 · The paper itself

Abstract

A working hypothesis is that less common species of Campylobacter (other than C. jejuni and C. coli) play a role in enteric disease among children in low resource settings and explain the gap between the detection of Campylobacter using culture and culture independent methods. "Candidatus Campylobacter infans" (C. infans), was recently detected in stool samples from children and hypothesized to play a role in Campylobacter epidemiology in low- and middle-income countries (LMIC). This study determined the prevalence of C. infans in symptomatic and asymptomatic stool samples from children living in Iquitos, Peru. Stool samples from 215 children with diarrhea and 50 stool samples from children without diarrhea under the age of two were evaluated using a multiplex qPCR assay to detect Campylobacter spp. (16S rRNA), Campylobacter jejuni / Campylobacter coli (cadF gene), C. infans (lpxA), and Shigella spp. (ipaH). C. infans was detected in 7.9% (17/215) symptomatic samples and 4.0% (2/50) asymptomatic samples. The association between diarrhea and the presence of these targets was evaluated using univariate logistic regressions. C. infans was not associated with diarrhea. Fifty-one percent (75/146) of Campylobacter positive fecal samples were negative for C. jejuni, C. coli, and C. infans via qPCR. Shotgun metagenomics confirmed the presence of C. infans among 13 out of 14 positive C. infans positive stool samples. C infans explained only 20.7% of the diagnostic gap in stools from children with diarrhea and 16.7% of the gap in children without diarrhea. We posit that poor cadF primer performance better explains the observed gap than the prevalence of atypical non-C. jejuni/coli species.

Indexed as

CampylobacterCampylobacter InfectionsChildDiarrheaFecesHumansPeruRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID36251729
PMCPMC9612815
OpenAlexW4306631590

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.